JYHZ2400273 | 替格瑞洛分散片 | ticagrelor | Tablet | Chemical Drugs | License Renew | 2024-10-12 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
JYHZ2100602 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | License Renew | 2021-08-11 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
JYHZ2100601 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | License Renew | 2021-08-11 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
JYHZ1700031 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | License Renew | 2017-06-26 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2017-09-12 | view |
JYHZ1700030 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | License Renew | 2017-06-26 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2017-09-12 | view |
JYHF1700105 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2017-11-06 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | Certificate Issued | 2017-12-04 | view |
JYHB2500156 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2025-03-14 | | AstraZeneca AB | | | view |
JYHB2500155 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2025-03-14 | | AstraZeneca AB | | | view |
JYHB2500154 | 替格瑞洛分散片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2025-03-14 | | AstraZeneca AB | | | view |
JYHB2400401 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2024-07-27 | | AstraZeneca AB | | | view |
JYHB2400400 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2024-07-27 | | AstraZeneca AB | | | view |
JYHB2400399 | 替格瑞洛分散片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2024-07-27 | | AstraZeneca AB | | | view |
JYHB2200506 | 替格瑞洛分散片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2022-09-15 | | AstraZeneca AB | | | view |
JYHB2200505 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2022-09-15 | | AstraZeneca AB | | | view |
JYHB2200504 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2022-09-15 | | AstraZeneca AB | | | view |
JYHB2200107 | 替格瑞洛分散片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2022-03-03 | | AstraZeneca AB | | | view |
JYHB2200106 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2022-03-01 | | AstraZeneca AB | | | view |
JYHB2200105 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2022-03-01 | | AstraZeneca AB | | | view |
JYHB2101440 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2021-09-23 | | AstraZeneca AB | | | view |
JYHB2101439 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2021-09-23 | | AstraZeneca AB | | | view |